Centene (CNC) Stock Forecast & Price Target

Compare

2,999 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CNC Analyst Ratings

Hold

4 Buy

8 Hold

2 Sell

Based on 14 analysts giving stock ratings to

Centene

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CNC Stock 12 Month Forecast

Average Price Target

$43.23

▲(25.05% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $43.23 with a high forecast of $59.00 and a low forecast of $32.00. The average price target represents a 25.05% change from the last price of $34.57.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"$24","61":"$61","33.25":"$33.3","42.5":"$42.5","51.75":"$51.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":59,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$59.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":43.23076923076923,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$43.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$32.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,33.25,42.5,51.75,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.6,45.70769230769231,46.815384615384616,47.92307692307693,49.03076923076923,50.13846153846154,51.246153846153845,52.353846153846156,53.46153846153846,54.56923076923077,55.676923076923075,56.784615384615385,57.892307692307696,{"y":59,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.6,44.49467455621302,44.38934911242604,44.28402366863906,44.17869822485207,44.07337278106509,43.96804733727811,43.86272189349113,43.757396449704146,43.652071005917165,43.54674556213018,43.441420118343196,43.336094674556215,{"y":43.23076923076923,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.6,43.63076923076923,42.66153846153846,41.69230769230769,40.723076923076924,39.753846153846155,38.784615384615385,37.815384615384616,36.84615384615385,35.87692307692308,34.90769230769231,33.93846153846154,32.96923076923077,{"y":32,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":58.16,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.45,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.41,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.91,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.65,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.91,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.62,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.74,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.15,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$59.00

Average Price Target$43.23

Lowest Price Target$32.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Scott Fidel

Goldman Sachs

$38→$32

Sell

-7.43%

Downside

Assigned

03/13/26

Goldman Sachs Remains a Sell on Centene (CNC)

Ann Hynes

Mizuho Securities

$47→$41

Hold

18.60%

Upside

Reiterated

03/11/26

Centene price target lowered to $41 from $47 at MizuhoCentene price target lowered to $41 from $47 at Mizuho

Andrew Mok CFA

Barclays

$54

Buy

56.20%

Upside

Reiterated

03/11/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Centene (NYSE: CNC) and LifeMD (NASDAQ: LFMD)

Erin Wright

Morgan Stanley

$38→$45

Hold

30.17%

Upside

Reiterated

03/04/26

Morgan Stanley Keeps Their Hold Rating on Centene (CNC)

David S Macdonald

Truist Financial

$47→$49

Buy

41.74%

Upside

Reiterated

02/25/26

Truist Financial Sticks to Their Buy Rating for Centene (CNC)

Stephen Baxter

Wells Fargo

$43→$44

Hold

27.28%

Upside

Reiterated

02/18/26

Centene (CNC) Gets a Hold from Wells Fargo

George Hill

Deutsche Bank

$32→$39

Hold

12.81%

Upside

Reiterated

02/10/26

Centene price target raised to $39 from $32 at Deutsche BankCentene price target raised to $39 from $32 at Deutsche Bank

Ryan Langston

TD Cowen

$34→$38

Hold

9.92%

Upside

Reiterated

02/10/26

Balanced Outlook: Raising Long-Term EPS and Target Price While Medicaid Headwinds Justify a Hold Rating

Michael Wiederhorn

Oppenheimer

$45

Buy

30.17%

Upside

Reiterated

02/09/26

Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (NASDAQ: CRDL) and Centene (NYSE: CNC)

Jason Cassorla

Guggenheim

―

Hold

―

Reiterated

02/09/26

Centene (CNC) Receives a Hold from Guggenheim

Sarah James

Cantor Fitzgerald

$41

Hold

18.60%

Upside

Reiterated

02/08/26

Centene (CNC) Gets a Hold from Cantor Fitzgerald

Kevin Fischbeck

Bank of America Securities

$32

Sell

-7.43%

Downside

Reiterated

02/06/26

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC) and Biogen (NASDAQ: BIIB)

Lance Wilkes

Bernstein

$59

Buy

70.67%

Upside

Reiterated

01/27/26

Centene (CNC) Receives a Buy from Bernstein

David Windley

Jefferies

$43

Hold

24.39%

Upside

Reiterated

01/07/26

Jefferies Remains a Hold on Centene (CNC)

John Stansel

J.P. Morgan

$38

Hold

9.92%

Upside

Reiterated

11/04/25

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC) and Cigna (NYSE: CI)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Scott Fidel

Goldman Sachs

$38→$32

Sell

-7.43%

Downside

Assigned

03/13/26

Goldman Sachs Remains a Sell on Centene (CNC)

Ann Hynes

Mizuho Securities

$47→$41

Hold

18.60%

Upside

Reiterated

03/11/26

Centene price target lowered to $41 from $47 at MizuhoCentene price target lowered to $41 from $47 at Mizuho

Andrew Mok CFA

Barclays

$54

Buy

56.20%

Upside

Reiterated

03/11/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Centene (NYSE: CNC) and LifeMD (NASDAQ: LFMD)

Erin Wright

Morgan Stanley

$38→$45

Hold

30.17%

Upside

Reiterated

03/04/26

Morgan Stanley Keeps Their Hold Rating on Centene (CNC)

David S Macdonald

Truist Financial

$47→$49

Buy

41.74%

Upside

Reiterated

02/25/26

Truist Financial Sticks to Their Buy Rating for Centene (CNC)

Stephen Baxter

Wells Fargo

$43→$44

Hold

27.28%

Upside

Reiterated

02/18/26

Centene (CNC) Gets a Hold from Wells Fargo

George Hill

Deutsche Bank

$32→$39

Hold

12.81%

Upside

Reiterated

02/10/26

Centene price target raised to $39 from $32 at Deutsche BankCentene price target raised to $39 from $32 at Deutsche Bank

Ryan Langston

TD Cowen

$34→$38

Hold

9.92%

Upside

Reiterated

02/10/26

Balanced Outlook: Raising Long-Term EPS and Target Price While Medicaid Headwinds Justify a Hold Rating

Michael Wiederhorn

Oppenheimer

$45

Buy

30.17%

Upside

Reiterated

02/09/26

Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (NASDAQ: CRDL) and Centene (NYSE: CNC)

Jason Cassorla

Guggenheim

―

Hold

―

Reiterated

02/09/26

Centene (CNC) Receives a Hold from Guggenheim

Sarah James

Cantor Fitzgerald

$41

Hold

18.60%

Upside

Reiterated

02/08/26

Centene (CNC) Gets a Hold from Cantor Fitzgerald

Kevin Fischbeck

Bank of America Securities

$32

Sell

-7.43%

Downside

Reiterated

02/06/26

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC) and Biogen (NASDAQ: BIIB)

Lance Wilkes

Bernstein

$59

Buy

70.67%

Upside

Reiterated

01/27/26

Centene (CNC) Receives a Buy from Bernstein

David Windley

Jefferies

$43

Hold

24.39%

Upside

Reiterated

01/07/26

Jefferies Remains a Hold on Centene (CNC)

John Stansel

J.P. Morgan

$38

Hold

9.92%

Upside

Reiterated

11/04/25

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC) and Cigna (NYSE: CI)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Centene

3 Months

xxx

Success Rate

33/51 ratings generated profit

Average Return

+3.23%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +3.23% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

26/51 ratings generated profit

Average Return

+4.63%

a rating ―

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 50.98% of your transactions generating a profit, with an average return of +4.63% per trade.

2 Years

xxx

Success Rate

26/51 ratings generated profit

Average Return

-0.40%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.98% of your transactions generating a profit, with an average return of -0.40% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CNC Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CNC has received 13 Buy Ratings, 14 Hold Ratings, and 2 Sell Ratings. CNC average Analyst price target in the past 3 months is 43.23.

Each month's total comprises the sum of three months' worth of ratings.

CNC Financial Forecast

CNC Earnings Forecast

Next quarter’s earnings estimate for CNC is $2.13 with a range of $0.41 to $2.89. The previous quarter’s EPS was -$1.19. CNC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.

CNC Sales Forecast

Next quarter’s sales forecast for CNC is $47.58B with a range of $46.91B to $48.97B. The previous quarter’s sales results were $49.73B. CNC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.

CNC Stock Forecast FAQ

What is CNC’s average 12-month price target, according to analysts?

Based on analyst ratings, Centene’s 12-month average price target is 43.23.

What is CNC’s upside potential, based on the analysts’ average price target?

Centene has 25.05% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CNC a Buy, Sell or Hold?

Centene has a consensus rating of Hold which is based on 4 buy ratings, 8 hold ratings and 2 sell ratings.

What is Centene’s price target?

The average price target for Centene is 43.23. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $59.00 ,the lowest forecast is $32.00. The average price target represents 25.05% Increase from the current price of $34.57.

What do analysts say about Centene?

Centene’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of CNC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Centene (CNC) Stock Forecast & Price Target

CNC Analyst Ratings

CNC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Centene

CNC Analyst Recommendation Trends

CNC Financial Forecast

CNC Earnings Forecast

CNC Sales Forecast

CNC Stock Forecast FAQ

Detailed List of Analyst Forecasts